Molecular Differences in Mitochondrial Genomes (Mitogenomes) of Dogs with Recurrent and Multiple Tumours and Their Reference to the Human Mitochondrial Genome
References
- Ambros B. (2015). The necrogeography of pet memorial spaces: pets as liminal family members in contemporary Japan. Material Religion, 6: 304–335.
- Anadol E., Yar Saglam A.S., Gultiken N., Karakas K., Alcigir E., Alkan H., Kanca H. (2017). Expression of iNOS, COX-2 and VEGF in canine mammary tumours and non-neoplastic mammary glands: Association with clinicopathological features and tumour grade. Acta Vet. Hung., 65: 382–393.
- Ashkenazy H., Abadi S., Martz E., Chay O., Mayrose I., Pupko T., Ben-Tal N. (2016). ConSurf 2016: an improved methodology to estimate and visualize evolutionary conservation in macromolecules. Nucleic Acids Res., 44: W344–W350.
- Bertagnolli A.C., Soares P., van Asch B., Amorim A., Cirnes L., Máximo V., Cassali G.D. (2009). An assessment of the clonality of the components of canine mixed mammary tumours by mitochondrial DNA analysis. Vet. J., 182: 269–274.
- Brønden L.B., Nielsen S.S., Toft N., Kristensen A.T. (2010). Data from the Danish Veterinary Cancer Registry on the occurrence and distribution of neoplasms in dogs in Denmark. Vet. Rec., 166: 586–590.
- Chen S., Zhou Y., Chen Y., Gu J. (2018). fastp: an ultra-fast all-in-one FASTQ preprocessor. Bioinformatics, 34: i884–i890.
- Cooley D.M., Schlittler D.L., Glickman L.T., Hayek M., Waters D.J. (2003). Exceptional longevity in pet dogs is accompanied by cancer resistance and delayed onset of major diseases. Journals Gerontol. Ser. A, 58: B1078–B1084.
- Danecek P., Bonfield J.K., Liddle J., Marshall J., Ohan V., Pollard M.O., Whitwham A., Keane T., McCarthy S.A., Davies R.M., Li H. (2021). Twelve years of SAMtools and BCFtools. Gigascience, 10: 1–4.
- den Dunnen J.T., Dalgleish R., Maglott D.R., Hart R.K., Greenblatt M.S., Mcgowan-Jordan J., Roux A.F., Smith T., Antonarakis S.E., Taschner P.E.M. (2016). HGVS recommendations for the description of sequence variants: 2016 update. Hum. Mutat., 37: 564–569.
- Deshpande M., Romanski P.A., Rosenwaks Z., Gerhardt J. (2020). Gynecological cancers caused by deficient mismatch repair and microsatellite instability. Cancers 2020, Vol. 12: Page 3319.
- Dobson J.M. (2013). Breed-predispositions to cancer in pedigree dogs. ISRN Vet. Sci., 2013: 1–23.
- Galadari S., Rahman A., Pallichankandy S., Thayyullathil F. (2017). Reactive oxygen species and cancer paradox: To promote or to suppress? Free Radic. Biol. Med., 104: 144–164.
- Garg P., Jadhav B., Lee, W., Rodriguez O.L., Martin-Trujillo A., Sharp A.J. (2022). A phenome-wide association study identifies effects of copy-number variation of VNTRs and multicopy genes on multiple human traits. Am. J. Hum. Genet., 109: 1065–1076.
- Gasteiger E., Hoogland C., Gattiker A., Duvaud S., Wilkins M.R., Appel R.D., Bairoch A. (2005). Protein identification and analysis tools on the ExPASy Server. In: The Proteomics Protocols Handbook, Walker J.M. (ed.). Humana Press, pp. 571–607.
- Gilkerson R.W., De vries R.L.A., Lebot P., Wikstrom J.D., Torgyekes E., Shirihai O.S., Przedborski S., Schon E.A. (2012). Mitochondrial autophagy in cells with mtDNA mutations results from synergistic loss of transmembrane potential and mTORC1 inhibition. Hum. Mol. Genet., 21: 978–990.
- Goldschmidt M.H., Peña L., Rasotto R., Zappulli V. (2011). Classification and grading of canine mammary tumors. Vet. Pathol., 48: 117–131.
- Grüntzig K., Graf R., Boo G., Guscetti F., Hässig M., Axhausen K.W., Fabrikant S., Welle M., Meier D., Folkers G., Pospischil A. (2016). Swiss Canine Cancer Registry 1955–2008: Occur-rence of the most common tumour diagnoses and influence of age, breed, body size, sex and neutering status on tumour development. J. Comp. Pathol., 155: 156–170.
- Grzybowska-Szatkowska L., Ślaska B., Rzymowska J., Brzozowska A., Floriańczyk B. (2014). Novel mitochondrial mutations in the ATP6 and ATP8 genes in patients with breast cancer. Mol. Med. Rep., 10: 1772–1778.
- Hendrick M. (1998). Histological classification of mesenchymal tumors of skin and soft tissues of domestic animals. Armed Forces Inst. Pathol., 2: 28–29.
- Imes D.L., Wictum E.J., Allard M.W., Sacks B.N. (2012). Identification of single nucleotide polymorphisms within the mtDNA genome of the domestic dog to discriminate individuals with common HVI haplotypes. Forensic Sci. Int. Genet., 6: 630–639.
- Inigo J.R., Chandra D. (2022). The mitochondrial unfolded protein response (UPR mt): shielding against toxicity to mitochondria in cancer. J. Hematol. Oncol., 15: 98.
- Keim P.S. (2013). Bacterial variable number tandem repeats. Brenner’s Encycl. Genet. Second Ed., pp. 274–276.
- Kim K.S., Lee S.E., Jeong H.W., Ha J.H. (1998). The complete nucleotide sequence of the domestic dog (
Canis familiaris ) mitochondrial genome. Mol. Phylogenet. Evol., 10: 210–220. - Klingemann H. (2018). Immunotherapy for dogs: Running behind humans. Front. Immunol., 9: 133.
- Kowal K., Ślaska B., Bownik A., Horecka B., Gawor J., Śmiech A., Tkaczyk A. (2019). Analysis of mitochondrial genome from labrador (
Canis lupus familiaris ) with mammary gland tumour reveals novel mutations and polymorphisms. Anim. Sci., 19: 619–632. - Kowal K., Tkaczyk A., Ząbek T., Pierzchała M., Ślaska B. (2020). Comparative analysis of CpG sites and islands distributed in mitochondrial DNA of model organisms. Animals, 10: 665.
- Kowal K., Tkaczyk-Wlizło A., Pierzchała, M., Gawor J., Ślaska B. (2022). Molecular differences in mitochondrial DNA genomes of dogs with malignant mammary tumours. Vet. Comp. Oncol., 20: 256–264.
- Kowal K., Tkaczyk-Wlizło A., Jusiak M., Grzybowska-Szatkowska L., Ślaska B. (2023). Canis MitoSNP database: a functional tool useful for comparative analyses of human and canine mitochondrial genomes. J. Appl. Genet., 64: 515–520.
- Kozakiewicz P., Grzybowska-Szatkowska L., Ciesielka M., Rzymowska J. (2021). The role of mitochondria in carcinogenesis. Int. J. Mol. Sci., 22: 5100.
- Lagouge M., Larsson N.G. (2013). The role of mitochondrial DNA mutations and free radicals in disease and ageing. J. Intern. Med., 273: 529–543.
- Li H. (2013). Aligning sequence reads, clone sequences and assembly contigs with BWA-MEM
https://doi.org./10.48550/arX-iv:1303.3997 . - Lowe T.M., Chan P.P. (2016). tRNAscan-SE On-line: integrating search and context for analysis of transfer RNA genes. Nucleic Acids Res., 44: W54–W57.
- Marwal A., Sahu A.K., Gaur R.K. (2014). Molecular markers: tool for genetic analysis. Anim. Biotechnol. Model. Discov. Transl., 289–305.
- Mestrinho L.A., Santos R.R. (2021). Translational oncotargets for immunotherapy: From pet dogs to humans. Adv. Drug Deliv. Rev., 172: 296–313.
- Okonechnikov K., Golosova O., Fursov M., Varlamov A., Vaskin Y., Efremov I., German Grehov O.G., Kandrov D., Rasputin K., Syabro M., Tleukenov T. (2012). Unipro UGENE: A unified bioinformatics toolkit. Bioinformatics, 28: 1166–1167.
- Rebhun R.B., Thamm D.H. (2010). Multiple distinct malignancies in dogs: 53 cases. J. Am. Anim. Hosp. Assoc., 46: 20–30.
- Rodríguez J., Santana Á., Herráez P., Killick D.R., de los Monteros A.E. (2022). Epidemiology of canine mammary tumours on the Canary Archipelago in Spain. BMC Vet. Res., 18: 268.
- Shidara Y., Yamagata K., Kanamori T., Nakano K., Kwong J.Q., Manfredi G., Oda H., Ohta S. (2005). Positive contribution of pathogenic mutations in the mitochondrial genome to the promotion of cancer by prevention from apoptosis. Cancer Res., 65: 1655–1663.
- Ślaska B., Grzybowska-Szatkowska L., Bugno-Poniewierska M., Surdyka M., Śmiech A. (2013). Nuclear and mitochondrial DNA mutation in human and canine tumors. Med. Weter., 69: 195–202.
- Ślaska B., Surdyka M., Brodzki A., Nisztuk S., Gurgul A., Bugno-Poniewierska M., Śmiech A., Różańska D., Orzelski M. (2014). Mitochondrial D-loop mutations can be detected in sporadic malignant tumours in dogs. Bull. Vet. Inst. Pulawy, 58: 631–637.
- Slaska B., Grzybowska-Szatkowska L., Nisztuk S., Surdyka M., Rozanska D. (2015). Mitochondrial DNA polymorphism in genes encoding
ND1 ,COI andCYTB in canine malignant cancers. Mitochondrial DNA, 26: 452–458. - Ślaska B., Grzybowska-Szatkowska L., Bugno-Poniewierska M., Gurgul A., Śmiech A., Rózańska D., Dudka J. (2016). Relevance of molecular changes in the
ND4 gene in German Shepherd Dog tumours. Pol. J. Vet. Sci., 19: 461–469. - Ślaska B., Śmiech A., Bownik A., Kowal K., Tkaczyk A., Pierzchała M., Dudka J. (2020). Defect in mitochondrial NADH-dehydrogenase genes in canine mast cell tumours. Ann.Anim.Sci., 20: 919–937.
- Śmiech A., Ślaska B., Surdyka M., Grzybowska-Szatkowska L., Łopuszyński W., Różańska D. (2016). Identification of additional mitochondrial DNA mutations in canine mast cell tumours. Acta Vet. Scand., 58: 28.
- Śmiech A., Łopuszyński W., Ślaska B., Bulak K., Jasik A. (2019). Occurrence and distribution of canine cutaneous mast cell tumour characteristics among predisposed breeds. J. Vet. Res., 63: 141–148.
- Surdyka M., Slaska B. (2017 a). Defect of the mitochondrial DNA hypervariable region as a risk factor for canine mammary tumour. Vet. Comp. Oncol., 15: 820–828.
- Surdyka M., Slaska B. (2017 b). Defect in
ND2 ,COX2 ,ATP6 andCOX3 mitochondrial genes as a risk factor for canine mammary tumour. Vet. Comp. Oncol., 15: 1062–1072. - Switonski M., Szczerbal I., Nowacka J. (2004). The dog genome map and its use in mammalian comparative genomics. J. Appl. Genet., 45: 195–214.
- Tamlin V.S., Bottema C.D.K., Woolford L., Dobson E.C., Kessell A.E., Peaston A.E. (2022). Canine mast cell tumours part I: Clinical and survival outcomes. Vet. Med. Sci., 8: 1409–1420.
- Tkaczyk-Wlizło A., Kowal K., Slaska B. (2022). Mitochondrial DNA alterations in the domestic dog (
Canis lupus familiaris ) and their association with development of diseases: A review. Mitochondrion, 63: 72–84. - Twig G., Shirihai O.S. (2011). The interplay between mitochondrial dynamics and mitophagy. Antioxid. Redox Signal., 14: 1939–1951.
- Van Gisbergen M.W., Voets A.M., Starmans M.H.W., de Coo I.F.M., Yadak R., Hoffmann R.F., Boutros P.C., Smeets H.J.M., Dubois L., Lambin P. (2015). How do changes in the mtDNA and mitochondrial dysfunction influence cancer and cancer therapy? Challenges, opportunities and models. Mutat. Res. – Rev. Mutat. Res., 764: 16–30.
- Wallace D.C. (2010). Mitochondrial DNA mutations in disease and aging. Environ. Mol. Mutagen., 51: 440–450.
- Wang T., Ma J., Hogan A.N., Bannasch D.L., Ostrander E.A., Correspondence T.I. (2020). Quantitative translation of dog-to-human aging by conserved remodeling of the DNA methylome. Cell Syst., 11: 176–185.e6.
- Yao Y., Dai W. (2014). Genomic instability and cancer. J. Carcinog. Mutagen., 5.
- Zapico S.C., Ubelaker D.H. (2013). mtDNA mutations and their role in aging, diseases and forensic sciences. Aging Dis., 4: 364–380.
- Zheng H.-H., Du C.-T., Yu C., Zhang R.-L., Huang R.-L., Tang X.-Y., Xie G.-H. (2022). Epidemiological investigation of canine mam-mary tumors in mainland China between 2017 and 2021. Front. Vet. Sci., 9: 843390.
Language: English
Page range: 89 - 97
Submitted on: Nov 5, 2022
Accepted on: May 23, 2023
Published on: Jan 23, 2024
Published by: National Research Institute of Animal Production
In partnership with: Paradigm Publishing Services
Publication frequency: 4 times per year
Keywords:
Related subjects:
© 2024 Krzysztof Kowal, Angelika Tkaczyk-Wlizło, Jan Gawor, Brygida Ślaska, published by National Research Institute of Animal Production
This work is licensed under the Creative Commons Attribution 4.0 License.